-
Recent Posts
- Dying Well at Home: Integrated Working (SCIE)
- Documentation for the National Dementia Prevalence Calculator (NHS England / Dementia Partnerships)
- Health, Housing and Ageing (Housing and Ageing Alliance / Housing LIN)
- Dementia Prevalence Calculator and Supporting Toolset (NHS England)
- EU ALCOVE Project: Latest Reports (ALCOVE Official Website / University of Worcester’s Association for Dementia Studies)
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Evidence
- NICE Guidelines
- NIHR
- NIHRSDO
- Patients Association
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Tag Archives: Atypical Antipsychotics
Antipsychotic Prescribing for Dementia Patients Declines in UK (BMJ Open)
Summary A cohort study into the pattern and trends in the use of antipsychotics and antidepressants etc. in Alzheimer’s Disease and other dementias has discovered that antipsychotic prescribing by GPs did fall markedly from 20% in 1995 to around 7% … Continue reading
Posted in Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, National, NHS, Pharmacological Treatments, Quick Insights, UK, Universal Interest
Tagged Acetylcholinesterase Inhibitors, AChEI, Antidementia Medications, Antidepressants, Antipsychotic Drug Prescribing in UK Mental Health Services, Antipsychotic Drugs, Antipsychotics, Antipsychotics in Elderly People with Dementia, Anxiolytics, Atypical Antipsychotics, BMJ Open, Call to Action on Antipsychotic Drugs (Dementia Action Alliance), Hypnotics, Im Dinkelfeld (Frankfurt), Memantine, Prescribing of Antipsychotic Drugs For People With Dementia, Research Institute for the Care of Older People: Royal United Hospital (Bath), Royal United Hospital (Bath), UK Clinical Practice Research Datalink (CPRD)
Leave a comment
Prescribing of Antipsychotics for Dementia Patients Declined Sharply in England 2006-2011 (Health and Social Care Information Centre)
[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 12, July 2012]. Summary The percentage of dementia patients being prescribed antipsychotic drugs fell sharply over the period 2006-2011 according to a statistical report … Continue reading
Posted in Antipsychotics, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), Management of Condition, National, NHS, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest
Tagged Antipsychotic Drugs, Antipsychotics, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, Clinical Audit Support Unit (CASU): Health and Social Care Information Centre, Diagnosis, Diagnosis and Assessment, England, Epidemiology, Health and Social Care Information Centre, Health and Social Care Information Centre: Clinical Audit Support Unit (CASU), HSCIC: Health and Social Care Information Centre, Inappropriate Prescribing, National Audit of Dementia, National Dementia and Antipsychotic Prescribing Audit 2012, NHS Information Centre, Percentage of People Diagnosed with Dementia with Antipsychotic Prescription 2006 - 2011, Prescribing of Antipsychotic Drugs For People With Dementia, Prevalence of Dementia, Quality and Outcomes Framework (QOF), Quality and Outcomes Framework (QOF) Dementia Registers, Right Prescription (Dementia Action Alliance)
Leave a comment
Antipsychotic Prescribing in Nursing Homes in the United States: Response to Regulatory Stringency (Health Economics)
Summary This paper studies the impact of regulatory stringency in the USA (as measured by the statewide deficiency citation rate over the past year) on the quality of care provided in a US national sample of nursing homes from 2000 … Continue reading
Posted in Antipsychotics, For Researchers (mostly), International, Pharmacological Treatments, Quick Insights
Tagged Antipsychotic Drugs, Antipsychotic Prescribing in Nursing Homes in the United States, Antipsychotics, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, Department of Economics and Scripps Gerontology Center: Miami University, Farmer School of Business: Miami University, Health Economics, Inappropriate Prescribing, Nursing Homes, Nursing Homes in the United States, Prescribing Anti-Psychotic Drugs to People with Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Regulatory Stringency, United States
Leave a comment